"MIATA"-minimal information about T cell assays
- PMID: 19833080
- PMCID: PMC3762500
- DOI: 10.1016/j.immuni.2009.09.007
"MIATA"-minimal information about T cell assays
Abstract
Immunotherapy, especially therapeutic vaccination, has a great deal of potential in the treatment of cancer and certain infectious diseases such as HIV (Allison et al., 2006; Fauci et al., 2008; Feldmann and Steinman, 2005). Numerous vaccine candidates have been tested in patients with a variety of tumor types and chronic viral diseases. Often, the best way to assess the clinical potential of these vaccines is to monitor the induced T cell response, and yet there are currently no standards for reporting these results. This letter is an effort to address this problem.
References
-
-
Allison, J.P., Dranoff, G., and Frederick, W. (2006) (San Diego: Elsevier Academic Press).
-
-
- Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, Martin M, Overbaugh J, Watkins DI, Mahmoud A, et al. Science. 2008;321:530–532. - PubMed
-
- Feldmann M, Steinman L. Nature. 2005;435:612–619. - PubMed
-
- Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, et al. J Immunother. 2007;30:1–15. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
